KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) EPS (Weighted Average and Diluted) (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed EPS (Weighted Average and Diluted) for 16 consecutive years, with $4.25 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, EPS (Weighted Average and Diluted) fell 3.85% year-over-year to $4.25, compared with a TTM value of $15.95 through Sep 2024, up 4.52%, and an annual FY2023 reading of $15.45, down 12.37% over the prior year.
  • EPS (Weighted Average and Diluted) was $4.25 for Q3 2024 at Thermo Fisher Scientific, up from $4.04 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $6.25 in Q4 2020 and bottomed at $1.97 in Q1 2020.
  • Average EPS (Weighted Average and Diluted) over 5 years is $4.22, with a median of $4.2 recorded in 2023.
  • The sharpest move saw EPS (Weighted Average and Diluted) soared 198.48% in 2021, then crashed 40.82% in 2023.
  • Year by year, EPS (Weighted Average and Diluted) stood at $6.25 in 2020, then tumbled by 33.12% to $4.18 in 2021, then dropped by 4.07% to $4.01 in 2022, then grew by 4.74% to $4.2 in 2023, then increased by 1.19% to $4.25 in 2024.
  • Business Quant data shows EPS (Weighted Average and Diluted) for TMO at $4.25 in Q3 2024, $4.04 in Q2 2024, and $3.46 in Q1 2024.